Literature DB >> 23298546

Coagulation and coagulation signalling in fibrosis.

Paul F Mercer1, Rachel C Chambers.   

Abstract

Following tissue injury, a complex and coordinated wound healing response comprising coagulation, inflammation, fibroproliferation and tissue remodelling has evolved to nullify the impact of the original insult and reinstate the normal physiological function of the affected organ. Tissue fibrosis is thought to result from a dysregulated wound healing response as a result of continual local injury or impaired control mechanisms. Although the initial insult is highly variable for different organs, in most cases, uncontrolled or sustained activation of mesenchymal cells into highly synthetic myofibroblasts leads to the excessive deposition of extracellular matrix proteins and eventually loss of tissue function. Coagulation was originally thought to be an acute and transient response to tissue injury, responsible primarily for promoting haemostasis by initiating the formation of fibrin plugs to enmesh activated platelets within the walls of damaged blood vessels. However, the last 20years has seen a major re-evaluation of the role of the coagulation cascade following tissue injury and there is now mounting evidence that coagulation plays a critical role in orchestrating subsequent inflammatory and fibroproliferative responses during normal wound healing, as well as in a range of pathological contexts across all major organ systems. This review summarises our current understanding of the role of coagulation and coagulation initiated signalling in the response to tissue injury, as well as the contribution of uncontrolled coagulation to fibrosis of the lung, liver, kidney and heart. This article is part of a Special Issue entitled: Fibrosis: Translation of basic research to human disease.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23298546     DOI: 10.1016/j.bbadis.2012.12.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

1.  Interstitial lung disease in patients with hepatopulmonary syndrome: a case series and new observations.

Authors:  S Shahangian; M Y Shino; I Barjaktarevic; I Susanto; J A Belperio; M C Fishbein; T Wang
Journal:  Lung       Date:  2014-03-30       Impact factor: 2.584

Review 2.  Mechanisms of alveolar epithelial injury, repair, and fibrosis.

Authors:  Rachel C Chambers; Paul F Mercer
Journal:  Ann Am Thorac Soc       Date:  2015-03

3.  Effect of ozone exposure and infection on bronchoalveolar lavage: sex differences in response patterns.

Authors:  Anatoly N Mikerov; David S Phelps; Xiaozhuang Gan; Todd M Umstead; Rizwanul Haque; Guirong Wang; Joanna Floros
Journal:  Toxicol Lett       Date:  2014-04-21       Impact factor: 4.372

Review 4.  Advances in functional and molecular MRI technologies in chronic liver diseases.

Authors:  Iris Y Zhou; Onofrio A Catalano; Peter Caravan
Journal:  J Hepatol       Date:  2020-06-22       Impact factor: 25.083

Review 5.  Platelet "first responders" in wound response, cancer, and metastasis.

Authors:  David G Menter; Scott Kopetz; Ernest Hawk; Anil K Sood; Jonathan M Loree; Paolo Gresele; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

Review 6.  Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.

Authors:  Maya M Juarez; Andrew L Chan; Andrew G Norris; Brian M Morrissey; Timothy E Albertson
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

Review 7.  Molecular imaging of fibrosis: recent advances and future directions.

Authors:  Sydney B Montesi; Pauline Désogère; Bryan C Fuchs; Peter Caravan
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

8.  A blood meal-induced Ixodes scapularis tick saliva serpin inhibits trypsin and thrombin, and interferes with platelet aggregation and blood clotting.

Authors:  Adriana M G Ibelli; Tae K Kim; Creston C Hill; Lauren A Lewis; Mariam Bakshi; Stephanie Miller; Lindsay Porter; Albert Mulenga
Journal:  Int J Parasitol       Date:  2014-02-28       Impact factor: 3.981

9.  Protease activated receptor 2 in diabetic nephropathy: a double edged sword.

Authors:  Arnold C Spek; Maaike Waasdorp; JanWillem Duitman; Sandrine Florquin; C Arnold Spek
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

10.  TGF-β1 Suppresses Plasmin and MMP Activity in Flexor Tendon Cells via PAI-1: Implications for Scarless Flexor Tendon Repair.

Authors:  Youssef M Farhat; Alaa A Al-Maliki; Anas Easa; Regis J O'Keefe; Edward M Schwarz; Hani A Awad
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.